Literature DB >> 32560765

Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence.

Bo Hu1, Qing Deng1, Qing Zhou2.   

Abstract

Entities:  

Keywords:  COVID-19; Cardiac marker; Myocardial injury; Myocarditis; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32560765      PMCID: PMC7295706          DOI: 10.1016/j.ijcard.2020.05.049

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
We thank the editors and researchers for their interest and comments in our recently published study [1]. Since the Coronavirus Disease-2019 (COVID-19) outbreak, several clinical studies [[1], [2], [3]] have discovered the evidence of myocardial injury as significant elevation of cardiac troponin among the infected patients, especially those required intensive care. However, it is inconclusive whether myocardium was injured directly by SARS-CoV-2 infection. From our experiences, myocardial injury is almost in COVID-19 patients of severe and critical types and/or with underlying cardiovascular diseases [[1], [2], [3]]. Once myocardial injury is present, fatal risk during hospitalization significantly increases. Thus, for improving clinical management and reducing mortality, the changes of cardiac marker levels and echocardiographic presentations should be closely monitored for these patients. Currently, the number of infected people has reached 3.6 million, while cases with myocarditis were extremely rare in the published clinical studies and case reports. Of note, two cases with suspected myocarditis underwent endomyocardial biopsy: molecular analysis of one case [4] showed absence of SARS-CoV-2 genome within myocardium and pathology of the other case [5] presented very low-grade myocardial inflammation, even clinical manifestations were similar to fulminant myocarditis. In line with our study [1], although SARS-CoV-2 infection can be detected in myocardial tissue, cardiac involvement of COVID-19 is possibly more integrated with systemic disorders. COVID-19-related myocarditis should be reviewed cautiously and thoroughly, including pathology and biopsy findings. Clinical investigation of SARS-CoV-2 myocarditis should focus on young patients without any underlying cardiovascular diseases. We look forward to novel discoveries and clinically valuable evidence regarding to cardiac involvement of COVID-19.

Grant supporting this paper

This work was supported by (Grant Numbers: 81971624 and 81901759).

Declaration of Competing Interest

The authors report no relationships that could be construed as a conflict of interest.
  5 in total

1.  Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study.

Authors:  Elisa Ceriani; Azzurra Marceca; Antonio Lanfranchi; Stefano De Vita; Riccardo Schiavon; Francesco Casella; Daniela Torzillo; Marta Del Medico; Diego Ruggiero; Alberto Barosi; Chiara Cogliati
Journal:  Intern Emerg Med       Date:  2021-05-21       Impact factor: 3.397

2.  Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients.

Authors:  Alberto Polimeni; Isabella Leo; Carmen Spaccarotella; Annalisa Mongiardo; Sabato Sorrentino; Jolanda Sabatino; Salvatore De Rosa; Ciro Indolfi
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

3.  Association between electrocardiographic features and mortality in COVID-19 patients.

Authors:  Daniel Antwi-Amoabeng; Bryce D Beutler; Sahajpreet Singh; Moutaz Taha; Jasmine Ghuman; Ahmed Hanfy; Nicholas T Manasewitsch; Mark B Ulanja; Joban Ghuman; Munadel Awad; Nageshwara Gullapalli; T David Gbadebo
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-03-19       Impact factor: 1.485

4.  Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection.

Authors:  Dominik Rath; Álvaro Petersen-Uribe; Alban Avdiu; Katja Witzel; Philippa Jaeger; Monika Zdanyte; David Heinzmann; Elli Tavlaki; Karin Müller; Meinrad Paul Gawaz
Journal:  Clin Res Cardiol       Date:  2020-06-14       Impact factor: 5.460

5.  The relation between left ventricular global longitudinal strain and troponin levels in patients hospitalized with COVID-19 pneumonia.

Authors:  Betul Balaban Kocas; Gokhan Cetinkal; Ozgur Selim Ser; Hakan Kilci; Kudret Keskin; Safiye Nur Ozcan; Yildiz Verdi; Mustafa Ismet Zeren; Kadriye Kilickesmez
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-18       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.